Bacteremic Pneumococccal Pneumonia: Current Therapeutic Options Charles Feldman and Ronald Anderson
... recommend the use of either a beta-lactam/macrolide combination or fluoroquinolone monotherapy for the empiric therapy of more severe hospitalized cases with pneumonia, including the subset of cases with pneumococcal bacteremia. There are a number of adjunctive therapies that have been studied for u ...
... recommend the use of either a beta-lactam/macrolide combination or fluoroquinolone monotherapy for the empiric therapy of more severe hospitalized cases with pneumonia, including the subset of cases with pneumococcal bacteremia. There are a number of adjunctive therapies that have been studied for u ...
Slide 1
... leukopenia, fever, electrolyte abnormalities, cardiac dysrhythmia Primaquine and clindamycin: methemoglobinemia and hemolysis, anemia, rash, fever, diarrhea ...
... leukopenia, fever, electrolyte abnormalities, cardiac dysrhythmia Primaquine and clindamycin: methemoglobinemia and hemolysis, anemia, rash, fever, diarrhea ...
Case Based Headache Management
... using the person trade-off method, which includes judgments about the trade-off between quality and quantity of life. Spectrum ranges from 0 (perfect health) to 1 (death). ...
... using the person trade-off method, which includes judgments about the trade-off between quality and quantity of life. Spectrum ranges from 0 (perfect health) to 1 (death). ...
Gabapentin - Vendor Drug Program
... 9. Dubinsky RM, Kabbani H, El-Chami Z, Boutwell C, Ali H. Practice Parameter: Treatment of postherpetic neuralgia: An evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2004;63;959-65. 10. Appleton R, Fichtner K, LaMoreaux L, et al. Gabapenti ...
... 9. Dubinsky RM, Kabbani H, El-Chami Z, Boutwell C, Ali H. Practice Parameter: Treatment of postherpetic neuralgia: An evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2004;63;959-65. 10. Appleton R, Fichtner K, LaMoreaux L, et al. Gabapenti ...
Reactive And Enteropathic Arthritis
... mice. These CTLs cross-reacted with peptides derived from mouse HSP60. A dodecamer derived from the intracytoplasmic tail of HLA-B27 was found to be a natural ligand for disease-associated HLA-B27 subtypes, but not for non-disease-associated subtypes. This peptide showed striking homology to a regio ...
... mice. These CTLs cross-reacted with peptides derived from mouse HSP60. A dodecamer derived from the intracytoplasmic tail of HLA-B27 was found to be a natural ligand for disease-associated HLA-B27 subtypes, but not for non-disease-associated subtypes. This peptide showed striking homology to a regio ...
The timely delivery of radical radiotherapy: standards
... asking the question, ‘Was the type of study done the strongest that could have been performed under the circumstances?’ He then recommends that Hill’s criteria for cause and effect relationships are applied to the entire body of evidence that bears on the question.34 There is strong evidence that in ...
... asking the question, ‘Was the type of study done the strongest that could have been performed under the circumstances?’ He then recommends that Hill’s criteria for cause and effect relationships are applied to the entire body of evidence that bears on the question.34 There is strong evidence that in ...
... permit overgrowth of clostridia . Studies indicate that a toxin produced by Clostridium difficile is a primary cause of "antibiotic-associated colitis" . After the diagnosis of pseudomembranous colitis has been established, therapeutic measures should be initiated . Mild cases of pseudomembranous co ...
Guidelines for the management of adult lower respiratory tract
... specific comment. As with other recommendations, these were based on evidence of both benefit and harm with respect to particular antibiotics. However, robust evidence to support individual recommendations was found to be absent. This was partly because individual antibiotic studies do not capture a ...
... specific comment. As with other recommendations, these were based on evidence of both benefit and harm with respect to particular antibiotics. However, robust evidence to support individual recommendations was found to be absent. This was partly because individual antibiotic studies do not capture a ...
Transcranial magnetic stimulation for the treatment of major
... Depression is a major contributor to disability worldwide. Further, its management can be a challenge for even experienced clinicians. Problems begin with recognizing and properly diagnosing patients who suffer from this disorder. For example, it is estimated that about half of the individuals in th ...
... Depression is a major contributor to disability worldwide. Further, its management can be a challenge for even experienced clinicians. Problems begin with recognizing and properly diagnosing patients who suffer from this disorder. For example, it is estimated that about half of the individuals in th ...
Tolosa-Hunt Syndrome with Facial Nerve Paresis
... may be confused with an attack of a complicated migraine but the presentation of painful ophthalmoplagia with ipsilateral multiple cranial nerve involvement suggestive of a structural lesion related event. Clinical findings in our patient fulfilled the ICHD-3 criteria for THS (Table 1) with the pres ...
... may be confused with an attack of a complicated migraine but the presentation of painful ophthalmoplagia with ipsilateral multiple cranial nerve involvement suggestive of a structural lesion related event. Clinical findings in our patient fulfilled the ICHD-3 criteria for THS (Table 1) with the pres ...
Myasthenia gravis: A comprehensive review of immune
... This form predominantly affects males, and it is distinct from LOMG, as patients do not present with thymoma [19]. In a study conducted in Italy between 1987 and 2007, the incidence of patients older than 50 years without thymoma tripled after 1990 [20]. Because the incidence of the EOMG did not inc ...
... This form predominantly affects males, and it is distinct from LOMG, as patients do not present with thymoma [19]. In a study conducted in Italy between 1987 and 2007, the incidence of patients older than 50 years without thymoma tripled after 1990 [20]. Because the incidence of the EOMG did not inc ...
Number 1 January/March 2015 Volume 21
... ready known. However, analyzes build upon the Virchow’s triad still do not have a direct answer to the question whether the occurrence of DVT is a result of dominant influence of one factor, or a result of cumulative action of several of them for long enough duration. It has already been proven th ...
... ready known. However, analyzes build upon the Virchow’s triad still do not have a direct answer to the question whether the occurrence of DVT is a result of dominant influence of one factor, or a result of cumulative action of several of them for long enough duration. It has already been proven th ...
Guidelines for the management of adult lower respiratory tract infections
... specific comment. As with other recommendations, these were based on evidence of both benefit and harm with respect to particular antibiotics. However, robust evidence to support individual recommendations was found to be absent. This was partly because individual antibiotic studies do not capture a ...
... specific comment. As with other recommendations, these were based on evidence of both benefit and harm with respect to particular antibiotics. However, robust evidence to support individual recommendations was found to be absent. This was partly because individual antibiotic studies do not capture a ...
PrXARELTO
... Patients with significant hepatic disease (eg, acute clinical hepatitis, chronic active hepatitis, liver cirrhosis) were excluded from clinical trials. Therefore, XARELTO is contraindicated in patients with hepatic disease (including Child-Pugh Class B and C) associated with coagulopathy, and having ...
... Patients with significant hepatic disease (eg, acute clinical hepatitis, chronic active hepatitis, liver cirrhosis) were excluded from clinical trials. Therefore, XARELTO is contraindicated in patients with hepatic disease (including Child-Pugh Class B and C) associated with coagulopathy, and having ...
Cassia fistula: A remedy from Traditional Persian Medicine for
... most important causes of death comprise superimposed opportunistic infections and complications of long-term high-dose corticosteroid therapy or prolonged consumption of immune suppressant drugs. Skin lesions are the most important sources of infection, and any local treatment decreasing the healing ...
... most important causes of death comprise superimposed opportunistic infections and complications of long-term high-dose corticosteroid therapy or prolonged consumption of immune suppressant drugs. Skin lesions are the most important sources of infection, and any local treatment decreasing the healing ...
Hereditary HAE with normal C1 inhibitor (HAE type three)
... Czaller I, Visy B, Csuka D, Füst G, Tóth F, Farkas H. The natural history of hereditary angioedema and the impact of treatment with human C1-inhibitor concentrate during pregnancy: a long-term survey. Eur J Obstet Gynecol Reprod Biol. 2010 Sep;152(1):44-9. Epub 2010 Jun 11. Farkas H, Czaller I, Csuk ...
... Czaller I, Visy B, Csuka D, Füst G, Tóth F, Farkas H. The natural history of hereditary angioedema and the impact of treatment with human C1-inhibitor concentrate during pregnancy: a long-term survey. Eur J Obstet Gynecol Reprod Biol. 2010 Sep;152(1):44-9. Epub 2010 Jun 11. Farkas H, Czaller I, Csuk ...
news release
... in the proxy statement for QLT's 2004 Annual Meeting of Shareholders, which was filed with the SEC as Exhibit 99.1 to Form 10-K/A on April 28, 2004. Information about the executive officers and directors of Atrix and their ownership of Atrix common stock is set forth in the proxy statement for Atrix ...
... in the proxy statement for QLT's 2004 Annual Meeting of Shareholders, which was filed with the SEC as Exhibit 99.1 to Form 10-K/A on April 28, 2004. Information about the executive officers and directors of Atrix and their ownership of Atrix common stock is set forth in the proxy statement for Atrix ...
Antibody-Directed Phototherapy (ADP)
... involving antibodies [8]. The majority of these are unconjugated antibodies whose function is primarily antagonistic, neutralizing or stimulation of the immune system. However, with approaching 15 years of clinical experience of monoclonal antibodies (MAbs) as approved drugs, it is becoming apparent ...
... involving antibodies [8]. The majority of these are unconjugated antibodies whose function is primarily antagonistic, neutralizing or stimulation of the immune system. However, with approaching 15 years of clinical experience of monoclonal antibodies (MAbs) as approved drugs, it is becoming apparent ...
Starting therapy with BETHKIS® (Tobramycin Inhalation Solution)
... Approximately 15 minutes each time ...
... Approximately 15 minutes each time ...
Fungal Infections-
... leukopenia, fever, electrolyte abnormalities, cardiac dysrhythmia Primaquine and clindamycin: methemoglobinemia and hemolysis, anemia, rash, fever, diarrhea www.aidsetc.org ...
... leukopenia, fever, electrolyte abnormalities, cardiac dysrhythmia Primaquine and clindamycin: methemoglobinemia and hemolysis, anemia, rash, fever, diarrhea www.aidsetc.org ...
NRC OI Fungal
... leukopenia, fever, electrolyte abnormalities, cardiac dysrhythmia Primaquine and clindamycin: methemoglobinemia and hemolysis, anemia, rash, fever, diarrhea ...
... leukopenia, fever, electrolyte abnormalities, cardiac dysrhythmia Primaquine and clindamycin: methemoglobinemia and hemolysis, anemia, rash, fever, diarrhea ...
Berberine Information - Health Walk Medical Clinic
... inhibitory effect on monamine oxidase enzymes (particularly MAO-A), much like some currently available prescription drugs. It also exerts a significant anti-anxiety effect, potentially through activation of 5-HT receptors in the brain. The type of modulatory activity that Berberine has on dopamine r ...
... inhibitory effect on monamine oxidase enzymes (particularly MAO-A), much like some currently available prescription drugs. It also exerts a significant anti-anxiety effect, potentially through activation of 5-HT receptors in the brain. The type of modulatory activity that Berberine has on dopamine r ...
1 Risk in Homeopathy: Classification of Adverse Events and
... Patient safety is central for all health care practices, both within conventional medicine as well as Complementary and Alternative Medicine (CAM). Patient safety can be understood as the reduction of the risk of unnecessary harm associated with health care interventions to an acceptable minimum (1) ...
... Patient safety is central for all health care practices, both within conventional medicine as well as Complementary and Alternative Medicine (CAM). Patient safety can be understood as the reduction of the risk of unnecessary harm associated with health care interventions to an acceptable minimum (1) ...
$doc.title
... clinical microbiology staff (and a limited number of other specialists in some circumstances). 3. Drugs listed on the HML and listed in this antimicrobial guideline are indicated with a superscript H (e.g. meropenemH) and are automatically approved for use for the condition and duration stated. 4. F ...
... clinical microbiology staff (and a limited number of other specialists in some circumstances). 3. Drugs listed on the HML and listed in this antimicrobial guideline are indicated with a superscript H (e.g. meropenemH) and are automatically approved for use for the condition and duration stated. 4. F ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.